EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 24 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $860,000 | -7.8% | 86,890 | -8.2% | 0.15% | +4.1% |
| Q1 2022 | $933,000 | -3.2% | 94,640 | -2.1% | 0.15% | +25.9% |
| Q4 2021 | $964,000 | -1.3% | 96,640 | -2.0% | 0.12% | -17.7% |
| Q3 2021 | $977,000 | -0.2% | 98,620 | +2.8% | 0.14% | -13.0% |
| Q2 2021 | $979,000 | +1.5% | 95,970 | 0.0% | 0.16% | -21.0% |
| Q1 2021 | $965,000 | -5.7% | 95,970 | 0.0% | 0.20% | -38.8% |
| Q4 2020 | $1,023,000 | – | 95,970 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|